Sanofi returns to Dren Bio for another B cell depletion therapy at $100M upfrontnews2025-12-15T14:51:09+00:00December 15th, 2025|Endpoints News|
Sanofi’s multiple sclerosis drug flunks Phase 3 trial, faces another PDUFA delaynews2025-12-15T12:19:41+00:00December 15th, 2025|Endpoints News|
Milestone finally wins FDA approval for arrythmia nasal spraynews2025-12-15T01:31:55+00:00December 15th, 2025|Endpoints News|
340B sales grew 23% last year, and court battle over pilot program intensifies news2025-12-12T20:47:51+00:00December 12th, 2025|Endpoints News|
CHMP calls to reject Anavex’s Alzheimer’s pill over impurities, side effects and weak efficacynews2025-12-12T17:27:18+00:00December 12th, 2025|Endpoints News|
GSK spins out corporate VC fund focused on bioelectronic technews2025-12-12T14:11:50+00:00December 12th, 2025|Endpoints News|
FDA broadens label for Amgen’s Uplizna as it enters rare disease competitionnews2025-12-12T12:03:56+00:00December 12th, 2025|Endpoints News|
CDC report underscores benefit of Covid-19 vaccines in kidsnews2025-12-11T20:51:34+00:00December 11th, 2025|Endpoints News|
Geron cuts one-third of staff, focusing on turning Rytelo launch aroundnews2025-12-11T20:24:29+00:00December 11th, 2025|Endpoints News|
EU forges deal over major pharma legislative changesnews2025-12-11T20:00:58+00:00December 11th, 2025|Endpoints News|
